Metformin targets multiple signaling pathways in cancer

被引：11

作者：

Yong Lei ^{[1
,2
]}

Yanhua Yi ^{[3
]}

Yang Liu ^{[1
,2
]}

Xia Liu ^{[1
,2
]}

Evan TKeller ^{[4
]}

ChaoNan Qian ^{[5
]}

Jian Zhang ^{[1
,2
,4
]}

Yi Lu ^{[1
,2
]}

机构：

[1] Key Laboratory of Longevity and Ageing-related Diseases,Ministry of Education

[2] Center for Translational Medicine,Guangxi Medical University

[3] School for International Education,Guangxi Medical University

[4] Department of Urology and Pathology,School of Medicine,University of Michigan

[5] Department of Nasopharyngeal Carcinoma,State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine,Sun Yat-sen University Cancer Center

来源：

Chinese Journal of Cancer | 2017年 / 36卷 / 07期

关键词：

Metformin; Signaling pathway; Cancer stem cell; Cancer;

D O I：

暂无

中图分类号：

R730.5 [肿瘤治疗学];

学科分类号：

100214 ;

摘要：

Metformin,an inexpensive and well-tolerated oral agent commonly used in the first-line treatment of type 2 diabetes,has become the focus of intense research as a candidate anticancer agent.Here,we discuss the potential of metformin in cancer therapeutics,particularly its functions in multiple signaling pathways,including AMP-activated protein kinase,mammalian target of rapamycin,insulin-like growth factor,c-Jun N-terminal kinase/mitogen-activated protein kinase(p38 MARK),human epidermal growth factor receptor-2,and nuclear factor kappaB pathways.In addition,cutting-edge targeting of cancer stem cells by metformin is summarized.

引用

页码：289 / 297

页数：9

共 52 条

[31]

Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance[J] . Ayesha B. Alvero,Rui Chen,Han-Hsuan Fu,Michele Montagna,Peter E. Schwartz,Thomas Rutherford,Dan-Arin Silasi,Karina D. Steffensen,Marianne Waldstrom,Irene Visintin,Gil Mor.Cell Cycle . 2009 (1)

[32] AMPK phosphorylation of raptor mediates a metabolic checkpoint [J].

Gwinn, Dana M. ;

Shackelford, David B. ;

Egan, Daniel F. ;

Mihaylova, Maria M. ;

Mery, Annabelle ;

Vasquez, Debbie S. ;

Turk, Benjamin E. ;

Shaw, Reuben J. .

MOLECULAR CELL, 2008, 30 (02) :214-226

[33] Role of the integrin αVβ3 in mediating increased smooth muscle cell responsiveness to IGF-I in response to hyperglycemic stress [J].

Clemmons, David R. ;

Maile, Laura A. ;

Ling, Yan ;

Yarber, J. ;

Busby, Walker H. .

GROWTH HORMONE & IGF RESEARCH, 2007, 17 (04) :265-270

[34]

AKT/PKB Signaling: Navigating Downstream[J] . Brendan D. Manning,Lewis C. Cantley.Cell . 2007 (7)

[35]

The Transcription Factor Nuclear Factor-kappa B and Cancer[J] . R.O. Escárcega,S. Fuentes-Alexandro,M. García-Carrasco,A. Gatica,A. Zamora.Clinical Oncology . 2006 (2)

[36]

Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance[J] . James A. McCubrey,Linda S. Steelman,William H. Chappell,Stephen L. Abrams,Ellis W.T. Wong,Fumin Chang,Brian Lehmann,David M. Terrian,Michele Milella,Agostino Tafuri,Franca Stivala,Massimo Libra,Jorg Basecke,Camilla Evangelisti,Alberto M. Martelli,Richard A. Franklin.BBA - Molecular Cell Research . 2006 (8)

[37]

TOR Signaling in Growth and Metabolism[J] . Stephan Wullschleger,Robbie Loewith,Michael N. Hall.Cell . 2006 (3)

[38] mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events [J].

Holz, MK ;

Ballif, BA ;

Gygi, SP ;

Blenis, J .

CELL, 2005, 123 (04) :569-580

[39]

Nuclear factor-κB[J] . Bharat B. Aggarwal.Cancer Cell . 2004 (3)

[40] The LKB1 tumor suppressor negatively regulates mTOR signaling [J].

Shaw, RJ ;

Bardeesy, N ;

Manning, BD ;

Lopez, L ;

Kasmatka, M ;

DePinho, RA ;

Cantley, LC .

CANCER CELL, 2004, 6 (01) :91-99

← 1 2 3 4 5 6 →